Drug Shortage Report for PMS-ESTRADIOL

Last updated on 2021-10-15 History
Report ID 87227
Drug Identification Number 02148595
Brand name ESTRACE
Common or Proper name ESTRADIOL
Company Name PHARMASCIENCE INC
Market Status DORMANT
Active Ingredient(s) ESTRADIOL
Strength(s) 2MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code G03CA
ATC description ESTROGENS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2019-07-01
Actual start date 2019-07-01
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2021-10-15
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 6111 ROYALMOUNT AVE
MONTREAL, QUEBEC
CANADA H4P 2T4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2021-10-15 French Compare
v8 2021-10-15 English Compare
v7 2019-07-02 French Compare
v6 2019-07-02 English Compare
v5 2019-07-02 English Compare
v4 2019-06-21 French Compare
v3 2019-06-21 English Compare
v2 2019-06-21 French Compare
v1 2019-06-21 English Compare

Showing 1 to 9 of 9